Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.

Mrozek-Gorska P, Buschle A, Pich D, Schwarzmayr T, Fechtner R, Scialdone A, Hammerschmidt W.

Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):16046-16055. doi: 10.1073/pnas.1901314116. Epub 2019 Jul 24.

2.

24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial.

Weinreb RN, Bacharach J, Fechtner RD, Kahook MY, Wirta D, Burmaster S, Meng X, Hubatsch DA.

Ophthalmology. 2019 Aug;126(8):1095-1104. doi: 10.1016/j.ophtha.2018.10.040. Epub 2018 Nov 4.

3.

Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results.

Dib Bustros Y, Fechtner R, S Khouri A.

J Curr Glaucoma Pract. 2017 May-Aug;11(2):42-47. doi: 10.5005/jp-journals-10028-1221. Epub 2017 Aug 5.

4.

Are Disposable and Standard Gonioscopy Lenses Comparable?

Lee B, Szirth BC, Fechtner RD, Khouri AS.

J Glaucoma. 2017 Apr;26(4):e157-e159. doi: 10.1097/IJG.0000000000000566.

PMID:
28121716
5.

Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma.

Li X, Mukkamala L, Origlieri CA, Holland BK, Fechtner RD, Khouri AS.

J Glaucoma. 2016 Oct;25(10):e855-e860.

PMID:
27367136
6.

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.

Fechtner RD, Myers JS, Hubatsch DA, Budenz DL, DuBiner HB.

Eye (Lond). 2016 Oct;30(10):1343-1350. doi: 10.1038/eye.2016.126. Epub 2016 Jul 1.

7.

New Technique of Exposed Glaucoma Drainage Tube Repair: Report of a Case.

Berezina TL, Fechtner RD, Cohen A, Kim EE, Chu DS.

J Curr Glaucoma Pract. 2015 May-Aug;9(2):62-4. doi: 10.5005/jp-journals-10008-1185. Epub 2015 Sep 25.

8.

Characteristics of Children With Primary Congenital Glaucoma Receiving Trabeculotomy and Goniotomy.

Mukkamala L, Fechtner R, Holland B, Khouri AS.

J Pediatr Ophthalmol Strabismus. 2015 Nov-Dec;52(6):377-82. doi: 10.3928/01913913-20151014-51.

PMID:
26584751
9.

Effect of age and disc size on rim order rules by Heidelberg Retina Tomograph.

Nayak NV, Berezina TL, Fechtner RD, Sinai MJ, Khouri AS.

J Glaucoma. 2015 Jun-Jul;24(5):377-82. doi: 10.1097/IJG.0b013e31829f9c15.

PMID:
26039385
10.

EX-PRESS glaucoma filtration device: Review of clinical experience and comparison with trabeculectomy.

Shaarawy T, Goldberg I, Fechtner R.

Surv Ophthalmol. 2015 Jul-Aug;60(4):327-45. doi: 10.1016/j.survophthal.2015.01.001. Epub 2015 Jan 24. Review. Erratum in: Surv Ophthalmol. 2015 Sep-Oct;60(5):508.

11.

Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.

Saade CE, Lari HB, Berezina TL, Fechtner RD, Khouri AS.

Can J Ophthalmol. 2015 Apr;50(2):132-6. doi: 10.1016/j.jcjo.2014.11.006.

PMID:
25863853
12.

Long term efficacy of repeat selective laser trabeculoplasty.

Khouri AS, Lari HB, Berezina TL, Maltzman B, Fechtner RD.

J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):444-8. doi: 10.4103/2008-322X.150814.

13.

Repeat selective laser trabeculoplasty can be effective in eyes with initial modest response.

Khouri AS, Lin J, Berezina TL, Maltzman B, Fechtner RD.

Middle East Afr J Ophthalmol. 2014 Jul-Sep;21(3):205-9. doi: 10.4103/0974-9233.134668.

14.

Combined pars plana vitrectomy and pars plana Baerveldt tube placement in eyes with neovascular glaucoma.

Kolomeyer AM, Seery CW, Emami-Naeimi P, Zarbin MA, Fechtner RD, Bhagat N.

Retina. 2015 Jan;35(1):17-28. doi: 10.1097/IAE.0000000000000235.

PMID:
25046391
15.

Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice.

Holló G, Topouzis F, Fechtner RD.

Expert Opin Pharmacother. 2014 Aug;15(12):1737-47. doi: 10.1517/14656566.2014.936850. Epub 2014 Jul 5. Review.

PMID:
24998246
16.

Selective laser trabeculoplasty: Does energy dosage predict response?

Habib L, Lin J, Berezina T, Holland B, Fechtner RD, Khouri AS.

Oman J Ophthalmol. 2013 May;6(2):92-5. doi: 10.4103/0974-620X.116635.

17.

Intraocular pressure outcomes after endophthalmitis associated with glaucoma surgery.

Mady RJ, Holland BK, Bhagat N, Zarbin MA, Fechtner RD, Khouri AS.

J Glaucoma. 2015 Feb;24(2):122-6. doi: 10.1097/IJG.0b013e31829da1cf.

PMID:
23807353
18.

Technique for removal of malpositioned Ex-PRESS glaucoma device.

Khouri AS, Khan MN, Fechtner RD, Vold SD.

J Glaucoma. 2014 Sep;23(7):435-6. doi: 10.1097/IJG.0b013e31827b1540.

PMID:
23221910
19.

Visual field and ocular safety during short-term vigabatrin treatment in cocaine abusers.

Berezina TL, Khouri AS, Winship MD, Fechtner RD.

Am J Ophthalmol. 2012 Aug;154(2):326-332.e2. doi: 10.1016/j.ajo.2012.02.026. Epub 2012 Jun 15.

PMID:
22704138
20.

Pars plana Baerveldt tube insertion with pars plana vitrectomy for refractory glaucoma.

Kolomeyer AM, Kim HJ, Khouri AS, Lama PJ, Fechtner RD, Zarbin MA, Bhagat N.

Oman J Ophthalmol. 2012 Jan;5(1):19-27. doi: 10.4103/0974-620X.94762.

21.

23-Gauge pars plana vitrectomy with pars plana Baerveldt tube placement for refractory glaucoma.

Kolomeyer AM, Fechtner RD, Zarbin MA, Bhagat N.

Eur J Ophthalmol. 2012 Jan-Feb;22(1):90-4. doi: 10.5301/ejo.5000027.

PMID:
22167547
22.

Technique for intraoperative reuse of Ex-PRESS delivery system.

Gregory L, Khouri AS, Lari HB, Fechtner RD.

J Glaucoma. 2013 Apr-May;22(4):e5-6. doi: 10.1097/IJG.0b013e318239c1bd.

PMID:
22134353
23.

A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry.

Kahook MY, Fechtner RD, Katz LJ, Noecker RJ, Ammar DA.

Curr Eye Res. 2012 Feb;37(2):101-8. doi: 10.3109/02713683.2011.631722. Epub 2011 Oct 31.

PMID:
22040280
24.

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost.

Fechtner RD, Harasymowycz P, Nixon DR, Vold SD, Zaman F, Williams JM, Hollander DA.

Clin Ophthalmol. 2011;5:945-53. doi: 10.2147/OPTH.S19999. Epub 2011 Jul 8.

25.

Peripheral visual field thresholds using Humphrey Field Analyzer program 60-4 in normal eyes.

Berezina TL, Khouri AS, Kolomeyer AM, Clancy PS, Fechtner RD.

Eur J Ophthalmol. 2011 Jul-Aug;21(4):415-21. doi: 10.5301/EJO.2011.6299.

PMID:
21279980
26.

Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.

Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC.

Cornea. 2010 Jun;29(6):618-21. doi: 10.1097/ICO.0b013e3181c325b2.

PMID:
20386433
27.

Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.

Roth DB, Verma V, Realini T, Prenner JL, Feuer WJ, Fechtner RD.

Ophthalmology. 2009 Mar;116(3):455-60. doi: 10.1016/j.ophtha.2008.10.002. Epub 2009 Jan 20.

PMID:
19157561
28.

Software-assisted optic nerve assessment for glaucoma tele-screening.

Khouri AS, Szirth BC, Shahid KS, Fechtner RD.

Telemed J E Health. 2008 Apr;14(3):261-5. doi: 10.1089/tmj.2007.0049.

PMID:
18570550
29.

Short-term complications of intravitreal injection of triamcinolone acetonide.

Roth DB, Realini T, Feuer WJ, Radhakrishnan R, Gloth J, Heimmel MR, Fechtner RD, Yarian DL, Green SN.

Retina. 2008 Jan;28(1):66-70. doi: 10.1097/IAE.0b013e3181593e38.

PMID:
18185140
30.

Use of fixed-dose combination drugs for the treatment of glaucoma.

Khouri AS, Realini T, Fechtner RD.

Drugs Aging. 2007;24(12):1007-16. Review.

PMID:
18020533
31.

DICOM transmission of simultaneous stereoscopic images of the optic nerve in patients with glaucoma.

Khouri AS, Szirth BC, Salti HI, Fechtner RD.

J Telemed Telecare. 2007;13(7):337-40.

PMID:
17958934
32.

Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology.

Lin SC, Singh K, Jampel HD, Hodapp EA, Smith SD, Francis BA, Dueker DK, Fechtner RD, Samples JS, Schuman JS, Minckler DS; American Academy of Ophthalmology; Ophthalmic Technology Assessment Committee Glaucoma Panel.

Ophthalmology. 2007 Oct;114(10):1937-49. Erratum in: Ophthalmology. 2008 Mar;115(3):472.

33.

Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology.

Dueker DK, Singh K, Lin SC, Fechtner RD, Minckler DS, Samples JR, Schuman JS.

Ophthalmology. 2007 Sep;114(9):1779-87.

PMID:
17822980
34.

Complications in resident-performed phacoemulsification cataract surgery at New Jersey Medical School.

Bhagat N, Nissirios N, Potdevin L, Chung J, Lama P, Zarbin MA, Fechtner R, Guo S, Chu D, Langer P.

Br J Ophthalmol. 2007 Oct;91(10):1315-7. Epub 2007 Apr 12.

35.

Evolving global risk assessment of ocular hypertension to glaucoma.

Fechtner RD, Khouri AS.

Curr Opin Ophthalmol. 2007 Mar;18(2):104-9. Review.

PMID:
17301610
36.

Screening and diabetes mellitus.

Khouri AS, Szirth BC, Bhagat N, Fechtner RD.

Ophthalmology. 2007 Feb;114(2):398-9; author reply 399-400. No abstract available.

PMID:
17270698
37.

Comparison of digital and film stereo photography of the optic nerve in the evaluation of patients with glaucoma.

Khouri AS, Szirth B, Realini T, Fechtner RD.

Telemed J E Health. 2006 Dec;12(6):632-8.

PMID:
17250484
38.

Intra-ocular pressure during lumbar disc surgery.

Turbin RE, Ahukanna I, Szirth BC, Grant G, Bennet HL, Fechtner RD.

Anaesthesia. 2007 Jan;62(1):91-2; author reply 92. No abstract available.

39.

Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results.

Fechtner RD, Khouri AS, Figueroa E, Ramirez M, Federico M, Dewey SL, Brodie JD.

Arch Ophthalmol. 2006 Sep;124(9):1257-62.

PMID:
16966620
40.

Laser suture lysis through thick blebs using the Blumenthal lens.

Khouri AS, Forofonova TI, Fechtner RD.

Arch Ophthalmol. 2006 Apr;124(4):544-5. No abstract available.

PMID:
16606881
41.

Ultrasound biomicroscopy demonstrating etiology of a spontaneous filtering bleb.

Khouri AS, Newman FR, Fechtner RD.

Eye (Lond). 2006 Dec;20(12):1441-2. Epub 2006 Feb 24. No abstract available.

PMID:
16498431
42.

Detecting age-related macular degeneration: technologies are best compared when standardized.

Khouri AS, Szirth BC, Fechtner RD.

Arch Ophthalmol. 2005 Aug;123(8):1157; author reply 1157-8. No abstract available.

PMID:
16087862
44.

Risk assessment in the management of patients with ocular hypertension.

Weinreb RN, Friedman DS, Fechtner RD, Cioffi GA, Coleman AL, Girkin CA, Liebmann JM, Singh K, Wilson MR, Wilson R, Kannel WB.

Am J Ophthalmol. 2004 Sep;138(3):458-67. Review.

PMID:
15364230
45.

An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma.

Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN.

Am J Ophthalmol. 2004 Sep;138(3 Suppl):S19-31. Review.

PMID:
15364049
46.

The Proview phosphene tonometer fails to measure ocular pressure accurately in clinical practice.

Alvarez TL, Gollance SA, Thomas GA, Greene RJ, Marchetto PM, Moore EJ, Realini T, Liebmann JM, Ritch R, Lama P, Fechtner RD.

Ophthalmology. 2004 Jun;111(6):1077-85.

PMID:
15177956
47.

Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.

Whitson JT, Henry C, Hughes B, Lee DA, Terry S, Fechtner RD.

J Glaucoma. 2004 Apr;13(2):168-73.

PMID:
15097265
48.

Fixed combinations of topical glaucoma medications.

Fechtner RD, Realini T.

Curr Opin Ophthalmol. 2004 Apr;15(2):132-5. Review.

PMID:
15021225
49.

The uniocular drug trial and second-eye response to glaucoma medications.

Realini T, Fechtner RD, Atreides SP, Gollance S.

Ophthalmology. 2004 Mar;111(3):421-6.

PMID:
15019313
50.

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA; COSOPT versus XALATAN Study Groups.

Acta Ophthalmol Scand. 2004 Feb;82(1):42-8.

Supplemental Content

Loading ...
Support Center